BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4392026)

  • 41. Antihypertensive activity of metyrosine in spontaneously hypertensive rats and its enhancement by carbidopa.
    Scriabine A; Ludden CT; Sweet CS; Porter CC; Ulm EH; Stone CA; Watkins CJ; Wurtman RJ; Cronin BL
    Clin Sci Mol Med Suppl; 1978 Dec; 4():255s-257s. PubMed ID: 282064
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of arterial hypertension with guanethidine, 1-alpha-methyldopa and pargyline hydrochloride].
    Montoreano F; Abrahim H; Plotquin J
    Prensa Med Argent; 1966 Jun; 53(22):1248-51. PubMed ID: 5968337
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparison of efficacy and safety of pindolol and alpha-methyldopa in treatment of mild to moderate hypertension: results of a double-blind evaluative study.
    Beanlands DS; Allard PP; Wilson M; Orbeck KW; Helman AB; Lefebvre R
    Clin Invest Med; 1978; 1(3-4):139-45. PubMed ID: 391453
    [No Abstract]   [Full Text] [Related]  

  • 44. [What is safe in the therapy of hypertensive heart disease?].
    Motz W; Strauer BE
    Internist (Berl); 1985 Dec; 26(12):750-64. PubMed ID: 2867983
    [No Abstract]   [Full Text] [Related]  

  • 45. The effects of two centrally-acting anti-hypertensive drugs on the quality of life.
    Fletcher AE; Beevers DG; Dollery CT; Wilkinson R; Bulpitt CJ
    Eur J Clin Pharmacol; 1991; 41(5):397-400. PubMed ID: 1684749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
    Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
    Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
    [No Abstract]   [Full Text] [Related]  

  • 47. Hypertension: a controllable disease.
    Freis ED
    Clin Pharmacol Ther; 1972; 13(5):627-32. PubMed ID: 5053807
    [No Abstract]   [Full Text] [Related]  

  • 48. Indapamide in ambulant treatment of hypertension: a comparative study with alpha-methyldopa.
    Meine H
    Postgrad Med J; 1981; 57 Suppl 2():37-8. PubMed ID: 7322958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diltiazem prevents hypertrophy progression, preserves systolic function, and normalises myocardial oxygen utilisation in the spontaneously hypertensive rat.
    Tubau JF; Wikman-Coffelt J; Massie BM; Szlachcic J; Parmley WW; Sievers R; Henderson S
    Cardiovasc Res; 1987 Aug; 21(8):606-14. PubMed ID: 2965615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population.
    Xie RH; Guo Y; Krewski D; Mattison D; Nerenberg K; Walker MC; Wen SW
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):281-5. PubMed ID: 24139131
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renal artery dysplasia with hypertension in neurofibromatosis.
    Bourke E; Gatenby PB
    Br Med J; 1971 Sep; 3(5776):681-2. PubMed ID: 4998797
    [No Abstract]   [Full Text] [Related]  

  • 52. A comparison of guanacline with methyldopa in the treatment of hypertension.
    Jerums G; Ebringer A; Doyle AE
    Med J Aust; 1968 Sep; 2(11):466-8. PubMed ID: 4878667
    [No Abstract]   [Full Text] [Related]  

  • 53. Cardiac polyamine metabolism in spontaneously hypertensive rats: effect of antihypertensive treatment.
    Ruskoaho H; Raunio H
    J Hypertens Suppl; 1986 Dec; 4(6):S71-4. PubMed ID: 3475431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of labetalol and methyldopa in pregnancy-induced hypertension.
    Lamming GD; Symonds EB
    Br J Clin Pharmacol; 1979; 8(Suppl 2):217S-222S. PubMed ID: 526404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beta-blockers for hypertension: are they going out of style?
    Che Q; Schreiber MJ; Rafey MA
    Cleve Clin J Med; 2009 Sep; 76(9):533-42. PubMed ID: 19726558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents.
    Brunner HR; Waeber B; Ferguson RK; Turini GA; Gavras H
    Cardiology; 1979; 64 Suppl 1():88-95. PubMed ID: 42489
    [No Abstract]   [Full Text] [Related]  

  • 57. [Current treatment of hypertension].
    Halawa B
    Wiad Lek; 1980 Apr; 33(8):625-30. PubMed ID: 6105745
    [No Abstract]   [Full Text] [Related]  

  • 58. Labetolol--combined alpha and beta blockade for hypertension.
    Raftery EB
    Scott Med J; 1978 Oct; 23(4):279-80. PubMed ID: 31683
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hypertension--diuretics as antihypertensive agents].
    Ikeda T
    Nihon Rinsho; 1970 Apr; 28(4):1266-71. PubMed ID: 4913896
    [No Abstract]   [Full Text] [Related]  

  • 60. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?
    Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM
    BJOG; 2016 Jun; 123(7):1135-41. PubMed ID: 26259808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.